Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10588036 | Bioorganic & Medicinal Chemistry Letters | 2013 | 31 Pages |
Abstract
The onset of resistance to approved anti-AIDS drugs by HIV necessitates the search for novel inhibitors of HIV-1 reverse transcriptase (RT). Developing single molecular agents concurrently occupying the nucleoside and nonnucleoside binding sites in RT is an intriguing idea but the proof of concept has so far been elusive. As a first step, we describe molecular modeling to guide focused chemical syntheses of conjugates having nucleoside (d4T) and nonnucleoside (TIBO) moieties tethered by a flexible polyethylene glycol (PEG) linker. A triphosphate of d4T-6PEG-TIBO conjugate was successfully synthesized that is recognized as a substrate by HIV-1 RT and incorporated into a double-stranded DNA.
Keywords
TBDMSdNTPAZTd4TPPINNRTINRTINRTIsNNRTIsTRISdNMPSAR3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromideDMSOMOIMTTTEABbifunctionaltriethylammonium bicarbonateReverse transcriptasetert-butyldimethylsilylTris(hydroxymethyl)aminomethaneDissociation constantdeoxynucleoside triphosphateDimethyl sulfoxideStructure–activity relationshipwild typeMolecular weightHIV-1Human immunodeficiency virus type 1polyethylene glycolPEGPyrophosphatemultiplicity of infection
Related Topics
Physical Sciences and Engineering
Chemistry
Organic Chemistry
Authors
Dongyuan Piao, Aravind Basavapathruni, Pinar Iyidogan, Guangxiu Dai, Wolfgang Hinz, Adrian S. Ray, Eisuke Murakami, Joy Y. Feng, Fei You, Ginger E. Dutschman, David J. Austin, Kathlyn A. Parker, Karen S. Anderson,